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Cobalt is a transition element occurring in
four valences (0, +2, +3, and +4), the divalent
oxidation state being the most common.
Tungsten, also known as wolfram (W), is a
hard metal that can occur in the natural state
only in the form of chemical compounds
with other elements. Co is a major con-
stituent (5–10%) of hard metal alloys, mainly
based (> 80%) on tungsten carbide (W-C)
and small percentages of other carbides
(Lauwerys and Lison 1994). Other industrial
uses of Co include diamond polishing with
Co-containing disks and production of dry-
ing agents, pigments, and catalysts. W and its
alloys are used extensively for filaments for
electric lamps, electron and television tubes,
and metal evaporation work. W has no recog-
nized physiologic roles, whereas Co is a cofac-
tor of vitamin B12 and therefore is an essential
element (Taylor and Marks 1978).
Occupational exposure to Co can lead to
various lung diseases, such as interstitial pneu-
monitis, fibrosis, and asthma [Agency for
Toxic Substances and Disease Registry
(ATSDR) 1999; Cirla 1994; Lauwerys and
Lison 1994; Lison 1996; Nordberg 1994].
Although the mechanisms of Co-induced lung
toxicity are not completely known, there is evi-
dence from both in vivo and in vitro experi-
ments supporting the view that Co induces the
production of reactive oxygen species (ROS)
with subsequent oxidative stress [reviewed by
Lison et al. (2001); Nemery et al. (1994);
Salnikow et al. (2000)]. In addition, ROS gen-
eration by Co administration is significantly
increased by coexposure to W-C particles,
through a physical–chemical mechanism of
interaction (Lison et al. 1995). Although W-C
alone seems to cause marginal genotoxic effects
(De Boeck et al. 2003; Van Goethem et al.
1997), when administered alone it would be
unable to induce lung parenchymal lesions
(Lasfargues et al. 1992) and oxidative stress
(Lison et al. 1995). Although Co was classiﬁed
as group 2B, possibly carcinogenic to humans
[International Agency for Research on Cancer
(IARC) 1991], its association with W-C has
recently been included in group 2A, probably
carcinogenic to humans (IARC 2003).
Therefore, strict control of dust level and regu-
lar health monitoring are recommended for
workers employed in the hard metal industry,
where such a coexposure may occur.
Urinary Co excretion (Co-U) has been pro-
posed as a biomarker of exposure because of its
correlation with airborne Co concentration
(Alexandersson 1988; Apostoli et al. 1994;
Christensen and Poulsen 1994; Linnainmaa
and Kiilunen 1997; Scansetti et al. 1985).
Little information is available about W metab-
olism and kinetics, mainly because of the lack
of suitable methods for its determination in
biological matrices other than the relatively
recent and expensive technique based on
inductively coupled plasma–mass spectrometry
(ICP-MS). W measurement in urine has been
proposed as a suitable exposure biomarker in
the hard metal industry, where exposure to
W-C is variable and has been reported to reach
417 µg/m3 (Kraus et al. 2001).
A key issue for risk assessment in occupa-
tional health is the characterization of dose at
the target organ level. In the case of inhalable
pneumotoxic metals, such as Co and W, a
noninvasive method for sampling from the
lung would be extremely useful. Standard
methods for the evaluation of lung patho-
biology (bronchoscopy, induced sputum) have
a high degree of invasiveness, which limits
their applicability to occupational monitoring.
Exhaled breath condensate (EBC), obtained by
cooling exhaled air under condition of sponta-
neous breathing, is a new technique to assess
pulmonary status, and published data suggest
that its composition has a good correlation
with bronchoscopic specimens (Kharitonov
and Barnes 2001; Mutlu et al. 2001). EBC is a
noninvasive and simple procedure, and
portable devices have been developed; there-
fore, it has the potential for application in
occupational settings (Antczak and Gorski
2002; Lemiere 2002). Preliminary studies on
smokers and patients with chronic obstructive
pulmonary disease have revealed that several
toxic metals and trace elements are detectable
in EBC, raising the possibility of using this
new matrix to quantify the lung tissue dose of
pneumotoxic substances (Mutti et al. 2003).
Furthermore, EBC analysis can be used to
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The aim of the present study was to investigate whether exhaled breath condensate (EBC), a ﬂuid
formed by cooling exhaled air, can be used as a suitable matrix to assess target tissue dose and effects
of inhaled cobalt and tungsten, using EBC malondialdehyde (MDA) as a biomarker of pulmonary
oxidative stress. Thirty-three workers exposed to Co and W in workshops producing either diamond
tools or hard-metal mechanical parts participated in this study. Two EBC and urinary samples were
collected: one before and one at the end of the work shift. Controls were selected among nonexposed
workers. Co, W, and MDA in EBC were analyzed with analytical methods based on mass spectro-
metric reference techniques. In the EBC from controls, Co was detectable at ultratrace levels,
whereas W was undetectable. In exposed workers, EBC Co ranged from a few to several hundred
nanomoles per liter. Corresponding W levels ranged from undetectable to several tens of nanomoles
per liter. A parallel trend was observed for much higher urinary levels. Both Co and W in biological
media were higher at the end of the work shift in comparison with preexposure values. In EBC,
MDA levels were increased depending on Co concentration and were enhanced by coexposure to W.
Such a correlation between EBC MDA and both Co and W levels was not observed with urinary
concentration of either element. These results suggest the potential usefulness of EBC to complete
and integrate biomonitoring and health surveillance procedures among workers exposed to mixtures
of transition elements and hard metals. Key words: cobalt, exhaled breath condensate, hard metals,
lung, malondialdehyde, oxidative stress, tungsten. Environ Health Perspect 112:1293–1298 (2004).
doi:10.1289/ehp.7108 available via http://dx.doi.org/ [Online 10 June 2004]quantify relevant biomarkers reflecting lipid
peroxidation of membrane cells (Corradi
et al. 2003; Kharitonov and Barnes 2001;
Mutlu et al. 2001). To the best of our knowl-
edge, EBC analysis has never been used in
occupational settings.
The aim of the present study was to inves-
tigate whether EBC can be employed for a
better risk assessment among workers exposed
to pneumotoxic metals, using workers from
the hard metal industry as a ﬁrst paradigmatic
application.
Materials and Methods
Subjects. Thirty-three workers from three fac-
tories producing either diamond tools
(group A, n = 12 subjects; group B, n =1 1
subjects) or hard-metal inserts (group C,
n = 10 subjects) were recruited to participate
to this study. Groups A and B were exposed
either to Co and W-C powders, which were
mixed to produce hard-metal alloys by synter-
ization, or to metal dust originating from dry-
grinding activities. Subjects from group C
were exposed to metal dust produced during
the dry grinding of hard-metal pieces. Sixteen
adult healthy subjects, not occupationally
exposed to metals, were recruited as the control
group. Controls were defined as individuals
with normal spirometry and without a signiﬁ-
cant history of lung diseases.
Demographic and clinical data of partici-
pants are summarized in Table 1. Workers
belonging to groups A, B, and C presented
normal spirometric indexes, with the excep-
tion of a single worker (heavy smoker) from
group B showing mild airway obstruction.
Two subjects from group A and one from
group C had a history of mild intermittent
asthma, and both were under therapy with
inhaled salbutamol as needed. One subject
from group B had radiologic evidence of pul-
monary fibrosis ascribed to the occupational
exposure to hard metals. All other workers
were asymptomatic and did not refer a signiﬁ-
cant current or past respiratory diseases.
Symptoms of acute respiratory illness within
the 4 weeks preceding the study were ruled
out in all subjects. All workers participating in
the study denied vitamin B12 supplementa-
tion or beer drinking (which are potential
confounders as sources of Co) over the week
preceding the study.
Study design. Workers belonging to
groups A and C were evaluated both before
(~ 15 hr after the end of the last exposure) and
at the end of the same 8-hr work shift. Samples
from subjects in group B were obtained only at
the end of the work shift. In addition to EBC
and urine collection, a short questionnaire
about current and past medical history was
completed and a spirometry was performed.
We carried out the same procedures in con-
trols in our laboratory during a normal work-
ing day. In order to verify whether possible air
contamination in the offices could influence
exhaled metals, three controls collected EBC
inside the offices of the plants. Because the
levels of Co and W in EBC of these subjects
were undetectable, we concluded that the con-
tamination of ofﬁce environmental air, if any,
provided a negligible contribution to the con-
centration of these elements in EBC.
All subjects enrolled in the study provided
written informed consent to the procedures,
which were approved by the local institutional
human ethical committee. The sampling of
biological material was carried out according to
the Declaration of Helsinki (World Medical
Association 2002).
Spirometric measurements. Spirometry was
performed with a pneumotachograph (Koko
Spirometer; Sensormedics, Milan, Italy). We
obtained mean values for forced expiratory vol-
ume in the ﬁrst second (FEV1) and forced vital
capacity (FVC) from the three best acceptable
test values of lung function, according to the
recommendation of the American Thoracic
Society (1995).
Environmental measurements. Environ-
mental monitoring was carried out by station-
ary samplers. The inhalable fraction of
particulate matter was collected using a selector,
following the procedures suggested by the
American Conference of Governmental
Industrial Hygienists (ACGIH 2003). Airborne
particulate was collected on cellulose ester
membranes (0.8 µm porosity, 25 mm diame-
ter) at a constant ﬂow of 3 L/min for a period
ranging from 4 to 7 hr during the same day of
biological monitoring. Membranes condi-
tioned before and after dust sampling were
weighted in a thermohygrometrically condi-
tioned cabinet using a precision microbalance
reading 0.0001 mg. Membranes were then
dissolved in concentrated hyperpure nitric
acid, and the solution was diluted with ultra-
pure water. The analytical blank was obtained
from virgin membranes, nitric acid, and water.
Co and W were analyzed by an ICP-MS
instrument using the same method applied to
analyze biological samples (Apostoli et al.
1998). Measured dusts were expressed as
micrograms per cubic meter.
Airborne concentrations of Co and W are
reported in Table 2. The highest concentra-
tions of Co and W were observed in factory 3
(group C). In factories 1 and 2 (groups A
and B, respectively), comparable Co levels
were observed, whereas factory 2 showed
slightly higher W levels.
We did not use personnel biomonitoring
of Co and W, mainly because, in the three
plants considered, the work places were very
narrow and the workers had almost no mobil-
ity within the working area. Therefore, the
collectors were placed in the proximity of the
workers’ breathing area. In addition, because
of the expected low airborne levels, the use of
stationary samplers allowed the use of higher
flow rates, thereby increasing sampling effi-
ciency and reducing analytical errors, which
may have a greater impact at relatively low
airborne concentrations.
EBC collection. EBC was collected with a
simple homemade apparatus formed by five
components: a)a   mouthpiece set up to work
also as a saliva trap; b)a   nonrebreathing
polypropylene valve; c)a   10-cm Tygon tube
(Nalgene 890 FEP tubing; Nalge Nunc
International, Rochester, New York, USA);
d)a  50-mL polypropylene vial; and e)a  Dewar
ﬂask refrigerated with gel refrigerant (Ice-Brix;
BDH Laboratory Supplies, Poole, Dorset,
UK); the apparatus was placed at –20°C the
night before the measurements. The ﬁve dis-
posable components can be easily assembled,
giving rise to simple portable apparatus essen-
tially composed of two parts: a)a   disposable
part, which is maintained at room temperature
and is composed of the mouthpiece with the
rebreathing valve and the tube (which connects
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Table 1. Demographic and clinical characteristics of study groups.
Characteristic Controls Group A Group B Group C
No. of subjects 16 10 11 12
Age (years) 34.8 ± 2.1 39.1 ± 3.9 33.2 ± 2.0 37.9 ± 3.2
Sex (male/female) 11/5 10/0 10/1 8/4
No. of current/ex-/never-smokers 6/1/9 4/5/1 8/0/3 6/0/6
Pack-years of current/ex-smokers (mean ± SEM) 10.2 ± 1.5/20 13.1 ± 5.9/10.2 ± 2.9 12.6 ± 4.5/0 7.8 ± 1.5/0
FVC, percent of predicted (mean ± SEM) 104.3 ± 4.3 114.7 ± 11.0 98.5 ± 2.8 117 ± 3.4
FEV1, percent of predicted (mean ± SEM) 102.5 ± 0.1 116.5 ± 8.4 96.3 ± 3.4 110 ± 3.5
FVC/FEV1, percent (mean ± SEM) 83.1 ± 0.01 84.5 ± 1.0 81.9 ± 2.09 98 ± 1.5
Table 2. Airborne concentrations (mg/m3) of Co and
W [median (range)] measured in the three working
environments. 
Group Co W
A 8.25 (0.1–16.4) < 0.01
B 8.45 (0.9–16.0) 0.10 (0.01–0.2)
C 26 (14.6–37.4) 3 (1.1–4.9)the valve to the vial); and b) the condensing
part, which is composed of a disposable vial
immersed in the refrigerant gel inside the
Dewar flask. Inside the Dewar flask kept at
room temperature, the gel refrigerant remains
completely frozen up to 6 hr at a constant tem-
perature (–20°C). Therefore, it can be used for
several EBC collections. Exhaled air condenses
along the internal surface of the vial, whose
temperature is close to –20°C. Upon conden-
sation, EBC droplets collect at the bottom of
the tube, which, unlike the tube walls, is not in
contact with the refrigerant gel; this keeps the
temperature slightly above 0°C. Therefore,
EBC collected with this device remains liquid.
This is an important feature because some pro-
teins and peptides may change their quaternary
structure and lose immunoreactivity upon
repeated thawing and freezing.
In EBC samples collected with this device
from 12 subjects, salivary contamination was
excluded through the colorimetric detection
of α-amylase (Infinity amylase reagent;
Sigma, St. Louis, MO, USA). Any possible
release of Co and W from plastics or contami-
nation during EBC collection was excluded in
repeated experiments made by extensive
washing of each component of the collection
circuit (data not shown).
Subjects were asked to breathe tidally
through the mouthpiece for 10 min, sitting
comfortably in the workplace ofﬁce (workers)
or in our laboratory (controls). Subjects were
instructed to form a complete seal around the
mouthpiece with their mouth and to maintain
a dry mouth during collection by periodically
swallowing excess saliva. In addition, they
were asked to rinse their mouths thoroughly
before the maneuver and each 5 min during
the test. To prevent any contamination from
skin, subjects were asked to wash their hands
before EBC and urine collection and to wear
disposable latex gloves during the collecting
procedures. EBC samples (almost 1 mL) were
transported in dry ice to the laboratory and
stored at –80°C in polypropylene tubes until
analytical determinations.
Analyses of Co and W in urine and EBC.
Co-U and urinary excretions of W (W-U) were
measured using flow injection (FI) ICP-MS
and expressed as a function of creatinine, as pre-
viously described (Apostoli et al. 1998).
The protocol used for water analysis was
applied to EBC samples because EBC does
not show any matrix effect. Brieﬂy, 2.5 mL of
ultrapure bidistilled water (MilliQ; Millipore,
Milan, Italy) was added to 0.5 mL EBC,
which was then vigorously shaken before
analysis by FI ICP-MS. We determined the
accuracy of methods by means of analyzing
standard reference material 1640 [National
Institute of Standards and Technology (NIST)
Gaithersburg, MD, USA]. The precision
expressed as coefﬁcient of variation varied from
4 to 8% among series and from 6 to 12%
between the series. The detection limit, deter-
mined on the basis of 3 SDs of the background
signal, was 0.003 µg/L for both Co and W.
The method for Co analysis in EBC was
compared with the most used technique relying
on atomic absorption spectroscopy with
Zeeman background correction (ETAAS-Z).
The agreement between the two methods was
assessed both by correlation analysis and by
applying the Bland-Altman method, a suitable
approach to verify the agreement between two
independent methods (Bland and Altman
1986), and is presented in Figure 1.
Determination of malondialdehyde
(MDA) in EBC. We determined MDA in
EBC (MDA-EBC) by liquid chromatography
tandem mass spectrometry (LC-MS/MS) using
an Applied Biosystems-Sciex API 365 triple
quadrupole mass spectrometer (Sciex, Concord,
Ontario, Canada) equipped with a heated
nebulized interface for atmospheric pressure
chemical ionization. Aldehydes were separated
by reversed-phase liquid chromatography after
derivatization with dinitrophenylhydrazine, as
previously described (Andreoli et al. 2003). The
limit of detection was 1.0 nmol/L of MDA,
and the limit of quantitation was 3 nmol/L.
Statistical analyses. Statistical analysis was
performed using SPSS 11.5 software (SPSS,
Chicago, IL, USA). When separate groups
were considered, Co and W in biological
media were not normally distributed. Also, the
corresponding log-transformed values did not
result in Gaussian distributions (one-sample
Kolmogorov-Smirnov Z and Shapiro-Wilk
test). Therefore, results were reported as median
and range, and Wilcoxon and Mann-Whitney
tests were used to assess differences between
groups. Owing to the lack of interference of
tobacco smoking on metal levels, further sta-
tistical analyses were performed irrespective of
smoking habits.
In the overall sample, all measured para-
meters showed a log-normal distribution
(Kolmogorov-Smirnov Z and Shapiro-Wilk
test). Therefore, all regression analyses were
performed on log-transformed values.
Pearson’s R was used to assess the correlation
between variables, with p-values < 0.05 (two-
tailed) considered statistically signiﬁcant. To
compare the difference between the slopes of
different regression lines, we used an appro-
priate form of Student’s t-test (Glantz 2002).
Finally, to assess the effect of Co and W on
the MDA levels, we performed an analysis of
covariance (ANCOVA) on log-transformed
values. The signiﬁcance level for all the used
tests was p = 0.05.
Results
Analytical determinations on urine and EBC
samples collected at the end of the work shift
are summarized in Table 3. In controls,
Co-EBC was measurable by ICP-MS but not
by ETAAS-Z, whereas both techniques revealed
measurable and much higher levels in all
exposed workers. We observed a similar behav-
ior for Co-U, whose values among exposed
workers were higher by several orders of 
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Figure 1. Correlation (A) and Bland-Altman graph (B) of the comparison between ETAAS-Z and FI ICP-MS
techniques for the measurements in 12 EBC samples. In (A), the solid line represents the best ﬁt of experi-
mental values, and the dashed line shows the theoretical identity line. In (B), the solid line shows the mean
deviation between the two methods; dashed lines indicate the mean ± 2 SD. A = –3.08381 ± 2.28647;
B =1 .14266 ± 0.01921; R = 0.99817; p < 0.0001.
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Table 3. End-of-shift values [median (interquartile range)] of biomarkers in the three factories.
Variables Controls (n = 16) Group A (n = 10) Group B (n = 11) Group C (n = 12)
Co-EBC (nmol/L) 0.7 (0.5–1.0) 40.7 (11.9–54.3)** 126 (44.1–628)** 163 (37.3–741)**
Co-U (µmol/mol creatinine) 0.09 (0.06–0.4) 2.9 (1.7–5.3)** 50.0 (16.2–366)** 18.9 (7.2–49.2)**
W-EBC (nmol/L) < 0.5 < 0.5 1.1 (0.5–4.9) 25.6 (15.2–76.1)
W-U (µmol/mol creatinine) < 0.06 (< 0.06 – 1.5) < 0.06 (< 0.06 – 1.0) 1.2 (0.6–4.9) 8.2 (3.2–16.1)
MDA-EBC (nmol/L) 7.6 (7.0–8.5) 11.5 (6.3–14.6) 14.2 (12.4–16.6)** 26.5 (6.5–44.0)*
Co, 1 nmol/L = 58.9 ng/L, 1 µmol/mol creatinine = 0.52 µg/g creatinine; W, 1 nmol/L = 185 ng/L, 1 µmol/mol creatinine
= 1.64 µg/g creatinine.
*p < 0.05 versus controls (Mann-Whitney test). **p < 0.01.magnitude compared with both controls and
the corresponding Co-EBC concentrations.
In samples collected before the work shift
among workers from group A, neither Co-EBC
[median, 2.0 nmol/L (interquartile range,
0.5–3.4 nmol/L)] nor Co-U [2.1 µmol/mol
creatinine (1.7–3.8 µmol/mol)] was signifi-
cantly different compared with controls. In
group C, basal levels of both Co-EBC [median,
57.7 nmol/L creatinine (interquartile range,
10.2–219.0 µmol/mol creatinine)] and Co-U
[7.8 µmol/mol creatinine (2.7–11.8 µmol/mol
creatinine)] were much higher than control
values (p < 0.01).
In workers from groups A and C, paired
analysis showed significant increases in
Co-EBC levels at the end of exposure com-
pared with values recorded before the working
shift (p < 0.01 and p < 0.05, respectively). In
workers from group C, but not from group A,
a significant difference between preexposure
and postexposure levels was observed for
Co-U (p < 0.01).
At both sampling times, W was not
detectable in EBC or in most urine samples
from group A workers and controls. In samples
collected from group C workers before the
working shift, W-EBC [median, 8.7 nmol/L
(interquartile range, 3.3–16.9)] and W-U
[2.3 µmol/mol creatinine (1.1–3.5 µmol/mol
creatinine)] were higher than were control val-
ues but about three times lower compared with
the corresponding postexposure levels reported
in Table 3 (p < 0.01).
MDA-EBC was measurable in all sam-
ples. In groups B and C, postexposure
MDA-EBC levels were higher than control
values (p < 0.01 and p < 0.05, respectively),
whereas the difference did not reach statistical
significance for less-exposed workers in
group A (p = 0.1). A significant increase in
MDA-EBC values over preexposure levels
[median, 9.2 nmol/L (interquartile range,
5.2–15.0 nmol/L )] was apparent in group C
(p < 0.01), whereas no differences in
MDA-EBC levels were observed in group A
compared with preexposure concentrations
[7.9 nmol/L (6.5–10.3 nmol/L)].
Co-EBC levels did not correlate with air-
borne Co (R = 0.27, p = 0.15). A positive cor-
relation between airborne Co and Co-U levels
was observed in groups A and C, either con-
sidered separately (R = 0.77, p < 0.01, and
R = 0.78, p < 0.01, respectively) or taken
together (R = 0.79, p < 0.01). The inclusion of
group B lowered the correlation coefficient
(R = 0.46, p < 0.01). In group B, the correla-
tion between airborne Co and Co-U levels
observed in groups A and C was no longer
apparent. In workers from group C only, a
positive correlation (R = 0.70, p < 0.05) was
observed between airborne W and W-U levels.
In group B, we observed an apparent
inconsistency between the relatively low 
airborne Co levels and the high concentrations
of Co-U. A possible explanation is represented
by poor hygienic conditions (a couple of
workers smoked during work hours), which
may lead to hand contamination and Co
absorption from routes other than inhalation
(dermal and oral).
In preexposure and postexposure pooled
samples (Figure 2A), Co-EBC was signiﬁcantly
related to W-EBC both for group B (R = 0.70,
p < 0.05) and group C (R = 0.72, p < 0.01),
although with a different slope (1.11 ± 0.41 for
group B vs. 0.50 ± 0.11 for group C,
mean ± SEM). In groups B and C, a similar
correlation was also found (Figure 2B) between
Co-U and W-U (R = 0.80, p < 0.01, and
R = 0.91, p < 0.01, respectively). Although we
observed no difference between the slopes of
the two regression lines (0.97 ± 0.27 for
group B vs. 0.86 ± 0.10 for group C), a shift
between the intercepts of the two regression
lines was evident.
In a pooled analysis of preexposure and
postexposure samples from all workers
(Figure 3A), Co-EBC correlated with Co-U
(R = 0.62, p < 0.01). A similar relationship on
pooled data (Figure 3B) was observed between
W-U and W-EBC (R = 0.48, p < 0.01).
In group C, MDA-EBC levels at both
times were significantly correlated with
Co-EBC (R = 0.91, p < 0.01) but not with
Co-U. In workers from groups A and B, such
a correlation was apparent in postexposure
samples (R = 0.68, p < 0.05, and R = 0.67,
p <0 .05, respectively). In group C, we also
found a correlation between W-EBC and
MDA-EBC (R = 0.77, p < 0.01).
To test whether the concomitant W expo-
sure interferes with Co pneumotoxicity, we
identiﬁed two different groups of workers on
the basis of the median of W-EBC. Regression
lines between Co-EBC and MDA-EBC among
subjects with W-EBC, respectively, lower and
higher than 16.3 nmol/L (Figure 4) showed
different slopes (mean ± SEM, 0.21 ± 0.04 vs.
0.37 ± 0.11; p < 0.01, Student’s t-test for the
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Figure 2. Correlation (A) between Co-EBC and W-EBC levels and (B) between Co-U and W-U levels. In (A),
group B log(W-EBC) = 2.44 + log(Co-EBC1.12)and Group C log(W-EBC) = 0.15 + log(Co-EBC0.51). In (B), group B
log(W-U) = 1.47 + log(Co-EBC0.97) and Group C log(W-U = 0.35 + log(Co-EBC0.86).
Figure 3. Correlation between (A) Co-U and Co-EBC levels and (B) between W-U and W-EBC levels. In (A),
log(Co-EBC) = 0.99 + log(Co-U0.79); in (B), log(W-EBC) = 0.65 + log(W-U0.59).
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Figure 4. Correlation between Co-EBC and MDA-EBC
levels. Group 1, workers with W-EBC < 16.3 nmol/L
[log(MDA-EBC) = 0.66 + log(Co-EBC0.21)]; group 2,
workers with W-EBC > 16.3 nmol/L [log(MDA-EBC)
=0.44 + log(Co-EBC0.37)].
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Regression line, group 2regression lines). In an ANCOVA model
using MDA-EBC as the dependent variable,
both W-EBC (p = 0.002) and Co-EBC
(p < 0.001) had a signiﬁcant inﬂuence on the
variability of MDA-EBC. A highly signiﬁcant
Co by W interaction was also observed
(p < 0.001). Interestingly, smoking habits did
not enter in the model either alone or in com-
bination with covariates.
Discussion
The present study demonstrates that Co and
W can be measured in the EBC of occupa-
tionally exposed workers and thus suggests
the potential use of this matrix as a novel
approach to monitor target tissue dose and
effects occurring in the respiratory tract upon
exposure to pneumotoxic substances. Indeed,
inhaled toxic chemicals can act locally on the
lung, which represents the route of entry of
most environmental pollutants.
Biological monitoring of exposure to trace
elements and toxic metals is mainly based on
their measurement in blood and urine.
However, these biomarkers integrate the over-
all intake from different absorption routes
and can be used to assess the risk of systemic
effects, rather than local effects on the respira-
tory tract. These limitations are conﬁrmed in
the present study by the lack of correlation
between either Co-U or W-U and MDA con-
centration in EBC. On the contrary, both Co
and W in EBC were correlated with
MDA-EBC levels, thus suggesting that
exhaled elements may reflect the lung dose
responsible for local toxic effects. In addition,
the relationship between Co levels in EBC
and urine seems to indicate that Co-EBC
really may represent the fraction of body dose
(represented by Co-U), which has been
inhaled and has not yet moved from lung tis-
sue in the systemic circulation at the sampling
time. However, the relatively weak (for W in
particular) correlation between Co and W
levels in EBC and the respective urinary levels
suggests that other absorption routes (i.e.,
dermal and oral absorption) may provide a
sizable contribution to absorbed dose and
subsequent urinary excretion. Furthermore,
the different bioavailability and solubility of
Co and W (Kraus et al. 2001) could account
for the weak correlation between the levels
into two compartments.
Because of the novelty of the EBC
measurements, the analytical validity of deter-
minations was strictly controlled. We
employed analytical methods based on mass
spectrometric reference techniques, namely,
LC-MS/MS for MDA and FI ICP-MS for
metals, in order to obtain accurate and reliable
results. Compared with other biological matri-
ces, such as urine and blood, EBC represents a
“clean” matrix, consisting mostly of water.
The reliability of the elemental measurements
in EBC was also assessed by performing the
analysis of Co in EBC samples with two tech-
niques relying on different principles, namely,
FI ICP-MS and ETAAS-Z. The results
showed a high repeatability, and therefore Co
in EBC can be easily measured relying on a
readily available technique such as ETAAS-Z.
The assessment of metal concentrations in
different biological ﬂuids can also provide use-
ful information about kinetics and a better
comprehension of physical–chemical interac-
tions between metals, for example, between Co
and W. In the present study, Co-U was related
to both air concentrations and Co-EBC,
despite the lack of correlation between Co-EBC
and airborne Co. This could be consistent with
a fast kinetic of inhaled Co, which can be read-
ily absorbed via the lungs in the organism
(ATSDR 1999). Therefore, we speculate that
Co-EBC reﬂects not only exposure but also the
amount of the element retained in the lung and
eliminated with exhaled air after its interaction
with—and possibly damage to—resident cells.
In fact, there is a relationship between
MDA-EBC (a marker of lipoperoxidation of
membranes) and Co-EBC, which might repre-
sent a marker of effective dose or dose at the
target. The correlation between MDA-EBC
and Co-EBC is consistent with the mechanism
of action of Co, which is known to cause oxida-
tive stress (Lewis et al. 1991; Lison et al. 1995,
2001; Nemery et al. 1994). Considering that
Co-U decreases rapidly (within 24 hr) after Co
exposure has ceased (Alexandersson 1988;
Apostoli et al. 1994), it is likely that the kinetics
of absorption of Co at the level of the primary
target organ (respiratory tract) are even faster.
This is also consistent with the drastic drop in
Co-EBC values at preexposure level about
16 hr after the last exposure.
A better understanding of the physical–
chemical interactions between Co and W
in vivo is another issue to which EBC can con-
tribute. Exposure to W was quite different
despite a similar productive cycle, probably
depending on a different composition of hard
metal alloys (covered by industrial secrets)
and, perhaps, on different behaviors of work-
ers from the point of view of personal hygiene.
In a couple of outliers, urinary levels were
higher by orders of magnitude than expected
on the basis of the corresponding air and EBC
concentrations. The significant Co-EBC by
W-EBC interaction in the ANCOVA model
with MDA-EBC as a dependent variable
strongly suggests that W exposure has a syner-
gistic effect in vivo on Co pneumotoxicity.
This is in agreement with published data
obtained from in vitro experiments (Lison
et al. 2001). In fact, although W-C alone is
known to be inert, there is some evidence that
the physical–chemical association of Co and
W-C generates electrons (provided by Co and
transferred on the surface of W-C), which can
reduce oxygen, thus giving rise to ROS (Lison
et al. 1995).
Although Figure 2 shows that the levels of
Co and W in EBC and urine are factory
dependent, the concentration of MDA in EBC
is strongly associated with both Co and W lev-
els in EBC, thus conﬁrming the most recent
understanding of hard metal lung disease as a
consequence of the combined effects of these
elements.
In conclusion, the present study shows
that EBC analysis is a promising matrix to
assess the target tissue dose of pneumotoxic
substances from polluted workplaces and to
assess early effect markers, such as MDA.
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